Environmental Impact in the Investment Strategy
The EMV Capital Group is uniquely positioned to play a major role in the environmental, social and corporate governance (“ESG”) and impact investment space, having traditionally been an investor in the core areas of healthcare around major chronic diseases for both therapeutics and diagnostics.
With the acquisition of EMV Capital, the Group also has capability and coverage of the sustainability area.
The Board of EMV Capital is now working towards embedding ESG considerations into its business, with meaningful steps taken during the year in its operations, investment activities and portfolio companies.
By going through potential portfolio company frameworks, EMV Capital identifies ESG areas that may need improvement. The Group targets research projects and sector specific relationship programmes which provide pre-vetted, high environmental impact deal flow opportunities.
Portfolio Company Case Studies

SageTech Medical is specialised in the removal of harmful CO2 emissions from exhaled anaesthetic gases in hospital operating theatres and veterinary practices.
Q-Bot insulation robots – how the latest in robotic technologies can save carbon emissions and money.
